Clinical treatment for hepatitis C reverses CYP2C19 inhibition-Reference-Cited by-同舟云学术

Clinical treatment for hepatitis C reverses CYP2C19 inhibition

Published:2021-04-12 Issue:10 Volume:87 Page:4013-4019
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit Jnl Clinical Pharma

Author:

Pippa Leandro Francisco¹^ORCID,Vieira Carolina Pinto¹^ORCID,Caris Juciene Aparecida²^ORCID,Rocha Adriana¹,Garcia Camile Prates³,Rezende Rosamar Eulira Fontes³⁴^ORCID,Lanchote Vera Lucia¹^ORCID

Affiliation:

1. Department of Clinical Analyses, Toxicology and Food Science, School of Pharmaceutical Sciences of Ribeirão Preto University of São Paulo Ribeirão Preto SP Brazil

2. Department of Neurosciences and Behavioural Sciences, School of Medicine of Ribeirão Preto University of São Paulo Brazil

3. Department of Internal Medicine, Division of Gastroenterology, School of Medicine of Ribeirão Preto University of São Paulo Brazil

4. Reference Centre, Hepatitis Outpatient Clinic, Municipal Health Secretary Ribeirão Preto São Paulo Brazil

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14829

Reference42 articles.

1. Cytochrome P450 (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database;Burns K;IUPHAR/BPS Guide Pharm CITE,2019

2. REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION

3. Cytokines influence mRNA expression of cytochrome P450 3A4 and MDRI in intestinal cells

4. Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics

5. Interleukin-6 and cytochrome-P450, reason for concern?

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics combined with network pharmacology reveals the protective effect of astragaloside IV on alcoholic liver disease;Phytomedicine;2024-12

2. The Impact of Inflammation on the In Vivo Activity of the Renal Transporters OAT1/3 in Pregnant Women Diagnosed with Acute Pyelonephritis;Pharmaceutics;2023-10-05

3. Effect of Chronic Hepatitis C on the Activity of the Membrane Transporters P‐gp and OATP1B1/BCRP on Patients With Different Stages of Hepatic Fibrosis;Clinical Pharmacology & Therapeutics;2023-05-16

4. A systematic review on disease‐drug‐drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labelling;British Journal of Clinical Pharmacology;2022-06-16